Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: loperamide hydrochloride

Summary for Generic Name: loperamide hydrochloride

Drug Master File Entries: see list10
Suppliers: see list21
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Clinical Trials for: loperamide hydrochloride

Imodium Syrup Versus Imodium Tablets for Faecal Incontinence
Status: Not yet recruiting Condition: Fecal Incontinence

Efficacy of Loperamide in Treating Patients for C. Difficile Colitis and Diarrheal Disease of Unknown Cause Associated With Antibiotic Therapy
Status: Recruiting Condition: Antibiotic Associated Diarrhea; Clostridium Difficile

Loperamide Grapefruit Juice Interaction PK Trial
Status: Completed Condition: Drug Interaction

A Comparison of Three Medications to Treat Diarrhea in Adults.
Status: Completed Condition: Diarrhea

Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe)
Status: Recruiting Condition: Fecal Incontinence

Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions
Status: Completed Condition: Healthy

Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time.
Status: Completed Condition: Intestinal Obstruction

Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea
Status: Completed Condition: Travelers' Diarrhea

Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects
Status: Completed Condition: Intestinal Obstruction

Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
Status: Completed Condition: Colorectal Cancer; Diarrhea

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Mcneil Cons
loperamide hydrochloride
CAPSULE;ORAL017694Approved Prior to Jan 1, 1982RXYes<disabled>
Mcneil Ped
loperamide hydrochloride
CAPSULE;ORAL017690Approved Prior to Jan 1, 1982DISCNNo<disabled>
Banner Pharmacaps
loperamide hydrochloride
CAPSULE;ORAL021855Aug 4, 2005OTCNo<disabled>
Banner Pharmacaps
loperamide hydrochloride
CAPSULE;ORAL021855Aug 4, 2005OTCYes<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology